CRON(Cronos Group Inc.) · 财务报表

CRON(Cronos Group Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$64.56M$86.75M$87.24M$117.61M$146.59M
毛利润−$17.59M$15.44M$11.91M$25.20M$62.76M
营业利润−$291.97M−$111.43M−$84.80M−$76.53M−$17.39M
净利润−$396.11M−$168.73M−$73.96M$41.08M−$9.45M
经营现金流−$153.62M−$88.95M−$42.84M$18.84M$25.87M
自由现金流−$164.76M−$92.40M−$45.34M$6.43M$149.00K
摊薄每股收益$-1.07$-0.45$-0.19$0.11$-0.02

Cronos Group Inc. CRON